Correction: Genomic Polymorphism of the Pandemic A (H1N1) Influenza Viruses Correlates with Viral Replication, Virulence, and Pathogenicity in Vitro and in Vivo (PLoS ONE (2011) 6:6 (e20698) DOI: 10.1371/journal.pone.0020698);Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivo

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Xu, Lili ^a   Bao, Linlin ^a   Zhou, Jianfang ^b   Wang, Dayan ^b   Deng, Wei ^a   Lv, Qi ^a   Ma, Yila ^a   Li, Fengdi ^a   Sun, Huihui ^a   Zhan, Lingjun ^a   Zhu, Hua ^a   Ma, Chunmei ^a   Shu, Yuelong ^b   Qin, Chuan ^a  

^a BEIJING HOSPITAL   (China)

^b National Institute for Viral Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PRIMER DNA;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; GENE SEQUENCE; GENETIC CODE; GENETIC POLYMORPHISM; GENOME ANALYSIS; GENOTYPE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MALE; MOLECULAR EVOLUTION; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PHENOTYPE; PRESCHOOL CHILD; RECEPTOR BINDING; SCHOOL CHILD; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DOG; GENETICS; PATHOGENICITY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIRULENCE;

ORTHOMYXOVIRIDAE;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DOGS; FEMALE; GENOME, VIRAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ALIGNMENT; VIRULENCE; VIRUS REPLICATION;

EID: 79958776585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0235911     Document Type: Erratum

References (55)

1. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
2. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, et al. (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361: 680-689.
3. Taubenberger JK, (2006) The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc 150: 86-112.
4. Glaser L, Stevens J, Zamarin D, Wilson IA, Garcia-Sastre A, et al. (2005) A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 79: 11533-11536.
5. Chen H, Bright RA, Subbarao K, Smith C, Cox NJ, et al. (2007) Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. Virus Res 128: 159-163.
6. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, et al. (2005) Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310: 77-80.
7. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, et al. (2004) Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A 101: 3166-3171.
8. Hatta M, Gao P, Halfmann P, Kawaoka Y, (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840-1842.
9. Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, et al. (2007) Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog 3: 1374-1379.
10. Zamarin D, Ortigoza MB, Palese P, (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80: 7976-7983.
11. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P, (2007) A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3: 1414-1421.
12. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, et al. (2002) Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A 99: 10736-10741.
13. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y, (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179.
14. Subbarao EK, London W, Murphy BR, (1993) A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67: 1761-1764.
15. Zhu H, Wang J, Wang P, Song W, Zheng Z, et al. (2010) Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice. Virology 401: 1-5.
16. Herfst S, Chutinimitkul S, Ye J, de Wit E, Munster VJ, et al. (2010) Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol 84: 3752-3758.
17. Jagger BW, Memoli MJ, Sheng ZM, Qi L, Hrabal RJ, et al. (2010) The PB2-E627K mutation attenuates viruses containing the 2009 H1N1 influenza pandemic polymerase. MBio 1: pii: e00067-00010.
18. Cao B, Li XW, Mao Y, Wang J, Lu HZ, et al. (2009) Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 361: 2507-2517.
19. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. The American Journal of Hygiene 27: 493-497.
20. Hayden FG, Cote KM, Douglas RG Jr, (1980) Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother 17: 865-870.
21. Auewarakul P, Suptawiwat O, Kongchanagul A, Sangma C, Suzuki Y, et al. (2007) An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 81: 9950-9955.
22. Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, et al. (1964) Antiviral Activity of 1-Adamantanamine (Amantadine). Science 144: 862-863.
23. Bao L, Xu L, Zhan L, Deng W, Zhu H, et al. (2010) Challenge and polymorphism analysis of the novel A (H1N1) influenza virus to normal animals. Virus Res 151: 60-65.
24. Xu L, Bao L, Lv Q, Deng W, Ma Y, et al. (2010) A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J 7: 325.
25. Cheung TK, Poon LL, (2007) Biology of influenza a virus. Ann N Y Acad Sci 1102: 1-25.
26. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
27. Potdar VA, Chadha MS, Jadhav SM, Mullick J, Cherian SS, et al. (2010) Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS One 5: e9693.
28. Ikonen N, Haanpaa M, Ronkko E, Lyytikainen O, Kuusi M, et al. (2010) Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland. PLoS One 5: e13329.
29. Kilander ARR, Dudman S, Hungnes O, (2010) Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15 pii.
30. Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, et al. (2010) Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol 84: 12069-12074.
31. Mak GC, Au KW, Tai LS, Chuang KC, Cheng KC, et al. (2010) Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 15.
32. Glinsky GV, (2010) Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations. Cell Cycle 9: 958-970.
33. Melidou A, Gioula G, Exindari M, Chatzidimitriou D, Diza E, et al. (2010) Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections. Virus Res 151: 192-199.
34. Hulse-Post DJ, Franks J, Boyd K, Salomon R, Hoffmann E, et al. (2007) Molecular changes in the polymerase genes (PA and PB1) associated with high pathogenicity of H5N1 influenza virus in mallard ducks. J Virol 81: 8515-8524.
35. Li Z, Chen H, Jiao P, Deng G, Tian G, et al. (2005) Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol 79: 12058-12064.
36. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, et al. (2005) The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A 102: 18590-18595.
37. Bussey KA, Bousse TL, Desmet EA, Kim B, Takimoto T, (2010) PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. J Virol 84: 4395-4406.
38. Zhou B, Li Y, Halpin R, Hine E, Spiro DJ, et al. (2011) PB2 Residue 158 Is a Pathogenic Determinant of Pandemic H1N1 and H5 Influenza A Viruses in Mice. J Virol 85: 357-365.
39. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, et al. (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2: 240-249.
40. Conenello GM, Palese P, (2007) Influenza A virus PB1-F2: a small protein with a big punch. Cell Host Microbe 2: 207-209.
41. Wanitchang A, Kramyu J, Jongkaewwattana A, (2010) Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein. Virus Res 147: 145-148.
42. Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, et al. (2010) PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol 84: 4442-4450.
43. Nelson M, Spiro D, Wentworth D, Beck E, Fan J, et al. (2009) The early diversification of influenza A/H1N1pdm. PLoS Curr 1: RRN1126.
44. Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, et al. (2010) Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol 84: 4194-4203.
45. Seo SH, Hoffmann E, Webster RG, (2002) Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8: 950-954.
46. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, et al. (2011) Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol 85: 1214-1223.
47. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, et al. (2009) Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 13: R201.
48. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207.
49. Skoner DP, Gentile DA, Patel A, Doyle WJ, (1999) Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis 180: 10-14.
50. Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V, (2008) Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 376: 53-59.
51. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, et al. (2004) Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431: 703-707.
52. Pappas C, Aguilar PV, Basler CF, Solorzano A, Zeng H, et al. (2008) Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A 105: 3064-3069.
53. Salomon R, Franks J, Govorkova EA, Ilyushina NA, Yen HL, et al. (2006) The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med 203: 689-697.
54. Vaillant L, La Ruche G, Tarantola A, Barboza P, (2009) Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 14.
55. Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, et al. (2009) Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 13: R148.